PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.14%
Negative revenue growth while JHX stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.14%
Negative gross profit growth while JHX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
133.30%
EBIT growth of 133.30% while JHX is zero. Bruce Berkowitz would see if small gains can be scaled further.
133.30%
Operating income growth of 133.30% while JHX is zero. Bruce Berkowitz would see if this modest edge can become significant.
-64.95%
Negative net income growth while JHX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.19%
10Y CAGR of 152.19% while JHX is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
40.64%
5Y CAGR of 40.64% while JHX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
2.58%
3Y CAGR of 2.58% while JHX is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.20%
10Y net income/share CAGR of 133.20% while JHX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
16.60%
Net income/share CAGR of 16.60% while JHX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-44.48%
Negative 3Y CAGR while JHX is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.